CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 27,600 | -43.4% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 48,800 | -6.2% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 52,000 | +10.6% | 0.00% | – |
| Q1 2022 | $3,000 | -89.7% | 47,000 | -28.5% | 0.00% | -100.0% |
| Q4 2021 | $29,000 | +7.4% | 65,700 | +19.9% | 0.00% | 0.0% |
| Q3 2021 | $27,000 | +3.8% | 54,800 | -22.9% | 0.00% | – |
| Q2 2021 | $26,000 | -46.9% | 71,100 | -35.9% | 0.00% | -100.0% |
| Q1 2021 | $49,000 | +48.5% | 110,900 | +142.1% | 0.00% | +200.0% |
| Q4 2020 | $33,000 | -21.4% | 45,800 | -7.8% | 0.00% | -50.0% |
| Q3 2020 | $42,000 | -91.9% | 49,700 | -74.0% | 0.00% | -93.1% |
| Q2 2020 | $521,000 | +3156.2% | 190,800 | +527.6% | 0.03% | +2800.0% |
| Q1 2017 | $16,000 | – | 30,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
| ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
| AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
| Platform Technology Partners | 60,000 | $75,000 | 0.04% |
| PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
| HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
| Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
| Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
| Aries Wealth Management | 23,400 | $33,000 | 0.02% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |